PUD Flashcards
H. pylori treatment begins with
inquire if patient has previous antibiotic exposure
(no 100% cure)
H.pylori treatment requires
3 or 4 agents for 10-14 days (acid suppressing, 2-3 antibiotics)
1st line treatment options
- clarithromycin triple
- bismuth quadruple
- non-bismuth based quadruple
clarithromycin triple therapy is
- PPI
- clarithromycin 500mg
- amoxicillin 1g
or
metronidazole 500mg
all BID
14 days
70-85% eradication
consider in non-penicillin allergy patients with NO previous macrolide exposure
bismuth quadruple therapy is
- PPI (BID)
- bismuth 120-300mg or bismuth 300mg (QID)
- metronidazole 250 or 500mg (QID)
- tetracycline 500mg (QID)
10-14days
75-90% eradication
consider in penicillin allergy pts
nonbismuth-based quadruple therapy is
- PPI (BID)
- amoxicillin 1g (BID)
- clarithromycin 500mg (BID)
- metronidazole 500mg (BID)
10-14 days
90% eradication
(similar to clarithromycin therapy except everything is added; eradication is higher)
sequential therapy is
- PPI (BID) and amoxicillin 1g (BID) then PPI (BID)
- clarithromycin 500mg(BID)
- metronidazole 500mg(BID)
5-7, then 5-7days (total 14)
>84% eradication
alternative or salvage therapy
hybrid therapy is
PPI(BID) + amoxicillin1g(BID), then:
PPI(BID) +
clarithromycin 500mg(BID)+
amoxicillin 1g(BID)+
metronizadole500mg(BID)
7, then 7days (total: 14d)
88.6% eradication
alternative or salvage therapy
levofloxacin-based is
PPI (BID)
levofloxacin 500mg (QD)
amoxicillin 1g (BID)
10-14 days
79-81% eradication
alternative or salvage
levofloxacin-sequential is
PPI (BID) + amoxicillin 1g (BID), then: PPI (BID) + levofloxacin 500mg (QD) + metronidazole 500mg (BID)
5-7, then 5-7days (total 14)
83.6-87.4% eradication
LOAD therapy is
PPI (double dose QD)
levofloxacin 250mg (QD)
nitazoxadine (Alina)500mg BID
(or metronidazole 500mg BID)
doxycycline 100mg (QD)
Peptic ulcer disease (PUD) associated with?
-H.pylori
-NSAIDs
-SRMD (stess-related mucosal damage)
prophylaxis candidates for NSAID-induced ulcers
> 60 y.o.
-past hx of PUD or GI events
-high NSAID dosage
-heart disease
-co-prescription of antiplatelets or low dose of aspirin, corticosteroids, and anticoagulants
prolonged NSAID-use
H. pylori infection
NSAID-induced ulcer (GU and DU) prevention
misoprostol or PPI
NSAID-induced ulcer treatment
-consider stopping NSAID
-eradicate H.pylori if +
-PPI for at least 8wks
if NSAID needs to be stopped, what’s the alternative?
sucralfate (for healing only)
PUD non-pharmacological interventions
similar to GERD
PUD pharmacological interventions
-acid suppression (antacids, H2RAs, PPIs)
-mucosal protection (sucralfate, colloidal bismuth, misoprostol)
-if H.pylori+, tx
sucralfate
in acid environment, turns into a viscous, sticky polymer that binds selectively to ulcers and erosions creating a protective barrier
efficacy compared to H2RAs
causes constipation & chelation
bismuth
MOA unclear
coats ulcers&erosions, creating a protective layer against acid & pepsin
-may stimulate PF and mucus secretion
-binds bacterial endotoxins=direct antimicrobial activity against H. pylroi
misoprostol (Cytotec)
a synthetic prostaglandin that replaces prostaglandins whose production is blocked by ASA or NSAIDs
-stimulates mucus and bicarbonate secretion; promotes mucosal defense
-replaced PG stores
-enhances mucosal blood flow
prevention of NSAID-induced ulcers in high-risk patients
another use is cervical ripening, labor induction in duction in premature rupture of membranes, post-partum hemorrhage
H. pylori eradication is standard care in patients with
gastric or duodenal ulcers
standard dosages for PPIs
omeprazole 20mg
rabeprazole 20mg
lansoprazole 30mg
pantoprazole 40mg
esomeprazole 40mg
all PO
salvage therapy
should include different antibiotics than the initial round
if both clarithromycin & metronidazole used as initial therapy, consider:
amoxicilling 1g BID
levofloxacin 250mg BID
PPI BID